FGD1, short for FYVE, RhoGEF and PH domain-containing 1, is a protein encoded by the FGD1 gene in humans. It is a guanine nucleotide exchange factor (GEF) for the Rho GTPase Cdc42, a key player in cell signaling pathways that regulate various cellular processes such as actin cytoskeleton organization, cell migration, and cell division.
The FGD1 protein is particularly noted for its role in the development and maintenance of the skeletal system. Mutations in the FGD1 gene are responsible for a rare genetic disorder known as Aarskog-Scott syndrome (also known as Faciogenital Dysplasia), characterized by short stature and abnormalities in the face, hands, and genitals. The disease primarily affects males, as the FGD1 gene is located on the X chromosomeThe protein's name (FYVE, RhoGEF, and PH domain-containing 1) refers to the three principal domains that characterize its structure: the FYVE domain, known to bind phosphatidylinositol 3-phosphate, a signaling lipid; the RhoGEF domain, responsible for its GEF activity towards Cdc42; and the PH (pleckstrin homology) domain, often involved in phospholipid binding and protein-protein interactions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor Inhibitor | 509093-47-4 | sc-204013 | 5 mg | $163.00 | 2 | |
Inhibits Cdc42 activation, potentially impacting FGD1's role in signaling pathways. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Inhibits myosin II, potentially influencing FGD1 in cytoskeletal regulation. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
An Arp2/3 complex inhibitor, could indirectly affect FGD1's role in actin cytoskeletal dynamics. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
Inhibits formin-mediated actin assembly, potentially impacting FGD1's function in cytoskeletal organization. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits the N-WASP-Arp2/3 interaction, which could indirectly influence FGD1 activity. | ||||||